Status:
COMPLETED
Interstitial Lung Disease is a Risk Factor for Cardiovascular Disease
Lead Sponsor:
Assiut University
Conditions:
Interstitial Lung Disease
Cardiovascular Morbidity
Eligibility:
All Genders
18+ years
Brief Summary
A group of Interstitial pulmonary fibrosis will be recruited from Assiut university hospital outpatient clinic. Evaluation will be done regarding cardiovascular comorbidities (Cardiovascular comorbid...
Detailed Description
Interstitial lung disease (ILD) is a chronic, progressive, parenchymal disease of the lungs. ILD has been associated with various cardiovascular co-morbidities, such as coronary artery disease (CAD) a...
Eligibility Criteria
Inclusion
- Patients diagnosed as Interstitial pulmonary fibrosis
Exclusion
- Patients refusing to participate in the study
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT06539962
Start Date
September 1 2023
End Date
October 1 2024
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Assiut University
Asyut, Egypt, 711111